Bedrocan Canada

Bedrocan Canada operates as a premier pharmaceutical grade medical cannabis enterprise solely dedicated to serving clinical research initiatives and healthcare patients. Originally brought to the public markets through a strategic reverse takeover backed by financial venture networks, the company established itself as a foundational leader in Canada’s federally regulated medicinal cannabis framework. By utilizing strict pharmaceutical cultivation methodologies, the corporation ensures that its standardized botanical varieties maintain a completely uniform composition of active cannabinoids across every single production cycle.

Initial corporate capitalization and rapid operational expansion were heavily accelerated by the PowerOne Group, which served as the sole agent, equity sponsor, and lead financial advisor across multi-million dollar private placements and public listings. Following these high profile capital market engagements, which earned top industry transaction awards from the Private Capital Markets Association, the entity completed a major merger with Tweed Marijuana Inc. to help form Canopy Growth Corp., creating the nation’s largest public medicinal cannabis organization at the time. Today, Bedrocan continues to leverage its extensive history of government regulated supply across global jurisdictions to deliver highly reliable, science based therapeutic options to patients and prescribing physicians worldwide.

Visit Website